Skip to main content
. 2023 Nov 13;29(12):3127–3136. doi: 10.1038/s41591-023-02635-7

Extended Data Table 4.

Effect of KT-474 on plasma cytokines and acute phase reactants in patients with HS and in patients with AD

graphic file with name 41591_2023_2635_Tab4_ESM.jpg

*Maximum % reduction through day 42. Analysis performed only on patients with values greater than the upper limit of normal at baseline. IL-6, IL-1β and CRP are high-sensitivity assays. NA, not analyzed.

Source data